News Daily News Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2 Michael O'Riordan January 03, 2024
News Daily News Top General Cardiology and CVD Prevention News of 2023 Yael L. Maxwell January 03, 2024
News Daily News Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients L.A. McKeown January 02, 2024
News Daily News High-Sensitivity Troponins Improve HEART Pathway in Chest Pain Workup Yael L. Maxwell December 21, 2023
News Daily News Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk Todd Neale December 12, 2023
News Daily News Family History of CVD? Low PUFA Intake May Add to Risk Michael O'Riordan December 12, 2023
News Daily News Rethink Race in Pooled Cohort Equations for ASCVD, REGARDS Data Suggest L.A. McKeown December 11, 2023
News Daily News Long-term ALLHAT Data Affirm Parity of Antihypertensive Meds Todd Neale December 06, 2023
News Daily News Optimal Care Reported in Less Than Half of Adults With ASCVD Yael L. Maxwell December 05, 2023
News Daily News JACC Statement Focuses on PAD Disparities, Gaps in Care L.A. McKeown December 04, 2023
News Daily News Short DAPT May Be Especially Beneficial for Women at High Bleeding Risk Yael L. Maxwell November 30, 2023
News Daily News High-Sensitivity Troponins May Overestimate PE Severity L.A. McKeown November 28, 2023
News Daily News No Adverse CV Effects of COVID-19 Vaccination Seen in Elite US Athletes Todd Neale November 23, 2023
News Daily News Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age People Todd Neale November 22, 2023
News Daily News ‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults Michael O'Riordan November 21, 2023
News Daily News Mortality Risk Varies Among Patients With Very High LDL Levels Michael O'Riordan November 17, 2023